Patents by Inventor John K. Maesaka

John K. Maesaka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020197652
    Abstract: A method is described to diagnose (1) renal salt wasting syndrome and (2) Alzheimer's disease among dementia patients by measuring a patient's level of prostaglandin D2 synthase. Methods are also described to (1) treat renal salt wasting syndrome, (2) inhibit the rate of apoptosis or (3) prevent the onset of, or slow the rate of, progression of Alzheimer's disease. These methods involve inhibiting the rate of −&Dgr;12prostaglandin J2 synthesis or by inhibiting the activity of −&Dgr;12prostaglandin J2.
    Type: Application
    Filed: June 25, 2002
    Publication date: December 26, 2002
    Applicant: Winthrop-University Hospital
    Inventor: John K. Maesaka
  • Patent number: 6458549
    Abstract: A method is described to diagnose (1) renal salt wasting syndrome and (2) Alzheimer's disease among dementia patients by measuring a patient's level of prostaglandin D2 synthase. Methods are also described to (1) treat renal salt wasting syndrome, (2) inhibit the rate of apoptosis or (3) prevent the onset of, or slow the rate of, progression of Alzheimer's disease. These methods involve inhibiting the rate of -&Dgr;12prostaglandin J2 synthesis or by inhibiting the activity of -&Dgr;12prostaglandin J2.
    Type: Grant
    Filed: June 11, 1998
    Date of Patent: October 1, 2002
    Assignee: Winthrop-University Hospital
    Inventor: John K. Maesaka
  • Publication number: 20010021508
    Abstract: A method is described to diagnose (1) renal salt wasting syndrome and (2) Alzheimer's disease among dementia patients by measuring a patient's level of prostaglandin D2 synthase. Methods are also described to (1) treat renal salt wasting syndrome, (2) inhibit the rate of apoptosis or (3) prevent the onset of, or slow the rate of, progression of Alzheimer's disease. These methods involve inhibiting the rate of -&Dgr;12prostaglandin J2 synthesis or by inhibiting the activity of -&Dgr;12prostaglandin J2.
    Type: Application
    Filed: June 11, 1998
    Publication date: September 13, 2001
    Inventor: JOHN K. MAESAKA